NCT02649673 2023-12-05
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
SCRI Development Innovations, LLC
Phase 1 Terminated
SCRI Development Innovations, LLC
Biologics & Biosimilars Collective Intelligence Consortium
Alliance for Clinical Trials in Oncology
Mt. Sinai Medical Center, Miami